JP2007522094A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007522094A5 JP2007522094A5 JP2006527154A JP2006527154A JP2007522094A5 JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5 JP 2006527154 A JP2006527154 A JP 2006527154A JP 2006527154 A JP2006527154 A JP 2006527154A JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5
- Authority
- JP
- Japan
- Prior art keywords
- kinase
- drug
- hexokinase
- complex
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50532503P | 2003-09-22 | 2003-09-22 | |
| US58183504P | 2004-06-22 | 2004-06-22 | |
| PCT/US2004/031147 WO2005030258A2 (en) | 2003-09-22 | 2004-09-22 | Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007522094A JP2007522094A (ja) | 2007-08-09 |
| JP2007522094A5 true JP2007522094A5 (enExample) | 2007-12-06 |
Family
ID=34396244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006527154A Abandoned JP2007522094A (ja) | 2003-09-22 | 2004-09-22 | 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1689439A2 (enExample) |
| JP (1) | JP2007522094A (enExample) |
| AU (1) | AU2004275770A1 (enExample) |
| CA (1) | CA2539914A1 (enExample) |
| WO (1) | WO2005030258A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| JP5230052B2 (ja) | 2000-05-26 | 2013-07-10 | イデニクス（ケイマン）リミテツド | フラビウイルスおよびペスチウイルス治療のための方法および組成物 |
| AP2005003213A0 (en) | 2002-06-28 | 2005-03-31 | Univ Cagliari | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections. |
| NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| US7824851B2 (en) | 2002-11-15 | 2010-11-02 | Idenix Pharmaceuticals, Inc. | 2′-branched nucleosides and Flaviviridae mutation |
| MXPA05006230A (es) | 2002-12-12 | 2005-09-20 | Idenix Cayman Ltd | Proceso para la produccion de nucleosidos ramificados-2'. |
| WO2007076160A2 (en) * | 2005-12-28 | 2007-07-05 | Acidophil Llc | C-10 carbamates of taxanes |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| KR101975843B1 (ko) | 2008-05-23 | 2019-05-09 | 더 유니버시티 오브 브리티쉬 콜롬비아 | 리포좀 나노입자에 사용하기 위한 변형된 약물 |
| EP2318832B1 (en) | 2008-07-15 | 2013-10-09 | Academia Sinica | Glycan arrays on ptfe-like aluminum coated glass slides and related methods |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| JP6302909B2 (ja) | 2012-08-18 | 2018-03-28 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | シアリダーゼの同定および画像化のための細胞透過性プローブ |
| WO2014033617A1 (en) | 2012-08-31 | 2014-03-06 | Novartis Ag | 2'-ethynyl nucleoside derivatives for treatment of viral infections |
| AU2013344757A1 (en) | 2012-11-19 | 2015-05-21 | Merck Sharp & Dohme Corp. | 2 -alkynyl substituted nucleoside derivatives for treating viral diseases |
| US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
| CA2923579C (en) | 2013-09-06 | 2023-09-05 | Academia Sinica | Human inkt cell activation using glycolipids with altered glycosyl groups |
| US9982041B2 (en) | 2014-01-16 | 2018-05-29 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| CN106415244B (zh) | 2014-03-27 | 2020-04-24 | 中央研究院 | 反应性标记化合物及其用途 |
| US20150344585A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| EP3904388A1 (en) | 2014-05-27 | 2021-11-03 | Academia Sinica | Fucosidase from bacteroides and methods using the same |
| CN106661099A (zh) | 2014-05-27 | 2017-05-10 | 中央研究院 | 抗her2醣抗体及其用途 |
| EP3154582A4 (en) | 2014-05-28 | 2018-01-10 | Academia Sinica | Anti-tnf-alpha glycoantibodies and uses thereof |
| EP3191500A4 (en) | 2014-09-08 | 2018-04-11 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| CA2972072A1 (en) | 2015-01-24 | 2016-07-28 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| KR20180114210A (ko) | 2016-03-08 | 2018-10-17 | 아카데미아 시니카 | N-글리칸의 모듈 합성 방법 및 그의 어레이 |
| US10538592B2 (en) | 2016-08-22 | 2020-01-21 | Cho Pharma, Inc. | Antibodies, binding fragments, and methods of use |
| EP3794015A4 (en) * | 2018-05-15 | 2022-03-30 | InterK Peptide Therapeutics Limited | ACTIVATING AGENT |
| CN112399970B (zh) * | 2018-05-15 | 2025-12-12 | 英特肽治疗有限公司 | 肽活化剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL59083A (en) * | 1979-01-10 | 1983-12-30 | Israel Marcus | Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor |
| US5608049A (en) * | 1995-03-10 | 1997-03-04 | Bristol-Myers Squibb Company | Preparation of d4T from 5-methyluridine |
| US5723589A (en) * | 1995-12-21 | 1998-03-03 | Icn Pharmaceuticals | Carbohydrate conjugated bio-active compounds |
-
2004
- 2004-09-22 JP JP2006527154A patent/JP2007522094A/ja not_active Abandoned
- 2004-09-22 WO PCT/US2004/031147 patent/WO2005030258A2/en not_active Ceased
- 2004-09-22 AU AU2004275770A patent/AU2004275770A1/en not_active Abandoned
- 2004-09-22 CA CA002539914A patent/CA2539914A1/en not_active Abandoned
- 2004-09-22 EP EP04784836A patent/EP1689439A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007522094A5 (enExample) | ||
| JP2007302683A5 (enExample) | ||
| JP2004516265A5 (enExample) | ||
| JP2003503454A5 (enExample) | ||
| NO20053245D0 (no) | Tabletter med modifisert frigjoring av bupropionhydroklorid. | |
| DE602004017510D1 (de) | Medizinprodukt vom kapseltyp | |
| ZA200704661B (en) | Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release | |
| JP2006517944A5 (enExample) | ||
| JP2009524695A5 (enExample) | ||
| MA28489B1 (fr) | Preparations pharmaceutiques | |
| NO332405B1 (no) | Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen. | |
| CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
| JP2007520565A5 (enExample) | ||
| WO2007144169A3 (en) | Entacapone-derivatives | |
| WO2008006795A3 (en) | Indole compounds | |
| WO2006095029A3 (en) | Di-polymer protein conjugates and processes for their preparation | |
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| FR2873690B1 (fr) | Derives d'oxopiperidine, leur preparation et leur application en therapeutique | |
| SI1718340T1 (sl) | Novi efektorski konjugati, postopek za njihovo proizvodnjo in njihova farmacevtska uporaba | |
| JP2008519810A5 (enExample) | ||
| JP2005508892A5 (enExample) | ||
| IL184487A0 (en) | N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application | |
| FR2912404B1 (fr) | Derives d'azabicycloalkane,leur preparation et leur application en therapeutique. | |
| JP2009536193A5 (enExample) | ||
| WO2007144699A3 (en) | Process for the preparation of alfuzosin |